Zobrazeno 1 - 9
of 9
pro vyhledávání: '"R. A. Naydenov"'
Autor:
A. G. Badoyan, A. P. Gorgulko, D. A. Khelimsky, O. V. Krestyaninov, T. A. Bergen, R. A. Naydenov, A. A. Baranov
Publikováno v:
Российский кардиологический журнал, Vol 27, Iss 8 (2022)
The coronary blood flow plays an important role in protecting the myocardium from ischemia and maintaining the cardiomyocyte function in the event of occlusion of one of the epicardial arteries. It also has a potential for restoring the contractile f
Externí odkaz:
https://doaj.org/article/eb28c9ba05dc4779b1bb8e4ef2829528
Autor:
O. V. Kamenskaya, I. Yu. Loginova, A. S. Klinkova, A. R. Tarkova, R. A. Naydenov, E. I. Kretov, V. V. Lomivorotov
Publikováno v:
Российский кардиологический журнал, Vol 25, Iss 6 (2020)
The article provides an overview of actual studies on cardiac rehabilitation using telehealth technologies, presents the types of telerehabilitation in clinical practice. The physiological mechanisms of exercise effects in rehabilitation programs in
Externí odkaz:
https://doaj.org/article/f971a6fcec6f4fb2a36bde38b8561af9
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 0, Iss 38, Pp 95-104 (2016)
Hypertrophic cardiomyopathy (HCMP) is a relatively common disease with genetic predisposition, that is widely spread irrespective of gender, race or ethnicity. The cause of this pathology are mutations of genes encoding synthesis of contracting prote
Externí odkaz:
https://doaj.org/article/73ebb453442a4a018320eb69ff3cc532
Publikováno v:
Complex Issues of Cardiovascular Diseases. 11:98-106
Highlights. The article analyzes the current evidence base for anticoagulant and antiplatelet therapy in patients with atrial fibrillation undergoing percutaneous coronary interventions, and future perspectives of such therapy.Abstract. A number of p
Publikováno v:
Патология кровообращения и кардиохирургия, Vol 24, Iss 2, Pp 9-15 (2020)
Chronic coronary total occlusions (CTOs) represent the most complex group of lesions in interventional cardiology, and technical success in their treatment depends on not only the characteristics of the lesions themselves but also the experience of t
Autor:
D. D. Zubarev, A B Romanov, I E Naryshkin, E. I. Kretov, N. R. Obedinskaya, A. A. Prokhorikhin, R. A. Naydenov, A V Biryukov, V. I. Baystrukov, E A Pokushalov, R. U. Ibragimov, O. V. Krestyaninov
Publikováno v:
Патология кровообращения и кардиохирургия, Vol 20, Iss 3, Pp 42-53 (2016)
Aim. The aim of this randomized study was to evaluate the safety and efficacy of septal myectomy (SM) and alcohol septal ablation (ASA) in patients with an obstructive form of hypertrophic cardiomyopathy.Methods. The study included 76 patients eligib
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 0, Iss 38, Pp 95-104 (2016)
Hypertrophic cardiomyopathy (HCMP) is a relatively common disease with genetic predisposition, that is widely spread irrespective of gender, race or ethnicity. The cause of this pathology are mutations of genes encoding synthesis of contracting prote
Publikováno v:
Патология кровообращения и кардиохирургия, Vol 24, Iss 3S, Pp 43-55 (2020)
Background. Coronary chronic total occlusion (CTO) is a common finding during routine coronary angiography. Despite significant progress in the technical success rate of CTO percutaneous coronary intervention over the last decade, indications for an
Autor:
E. I. Kretov, I. A. Naryshkin, R. A. Naydenov, D. D. Zubarev, V. I. Baystrukov, D. S. Grankin, A. A. Shermuk, D. A. Khelimskiy, R. U. Ibragimov, O. V. Krestyaninov
Publikováno v:
Patologiya krovoobrashcheniya i kardiokhirurgiya. 21:24
Aim. Coronary artery perforation (CAP) is a rare but severe complication of percutaneous coronary intervention (PCI). The aim of our study was to evaluate the effect and safety of transcatheter embolization by tissue adhesive Histoacryl when treating